SARS-CoV-2 infection and diabetes: Pathophysiological mechanism of multi-system organ failure

Area of Science:

• Medical Research
• Pathophysiology
• Infectious Diseases

Background:

• Diabetes mellitus is a major global health concern.
• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disproportionately affects individuals with pre-existing conditions.
• Co-infection with diabetes and SARS-CoV-2 exacerbates multi-system organ failure.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying multi-system organ failure in diabetic patients with SARS-CoV-2 infection.
• To review organ-specific pathophysiology induced by the co-existence of diabetes and SARS-CoV-2.
• To understand the accelerated disease progression and magnified severity in this patient population.

Main Methods:

• Literature review of existing studies on diabetes, SARS-CoV-2, and multi-system organ failure.
• Analysis of molecular pathways involved in organ-specific damage.
• Synthesis of current knowledge on the pathophysiology of co-infection.

Main Results:

• Both diabetes and SARS-CoV-2 independently contribute to multi-system organ failure.
• Co-infection accelerates disease progression and increases severity.
• Specific molecular mechanisms for organ damage in lungs, heart, kidneys, brain, eyes, gastrointestinal system, and bones are discussed.

Conclusions:

• The pathophysiology of multi-system organ failure in diabetic patients with SARS-CoV-2 infection remains incompletely understood.
• Further research is needed to clarify the precise molecular mechanisms.
• Understanding these mechanisms is crucial for developing targeted therapies and improving patient outcomes.